Remote neuromodulation may offer safe, effective relief for a range of migraine types, including those with aura and chronic ...

Primary care clinicians focus on acute migraine management, despite the chronic nature of this neurological disease.

Atogepant 60 mg vs rimegepant and galcanezumab for episodic migraine prevention has superior efficacy, with comparable safety ...

The trial’s primary goal was to assess the change in the number of migraine days per month from baseline over the first four ...

Symbravo ® (meloxicam and rizatriptan) is now available for the acute treatment of migraine with or without aura in adults.. Symbravo is an oral agent that consists of meloxicam, a COX-2 ...

MR is associated with better treatment response than gepants in patients with migraine who previously had an inadequate ...

SYMBRAVO represents a novel multi-mechanistic approach to treating migraine that addresses multiple pathways underlying a migraine attack SYMBRAVO On My Side offers comprehensive patient support ...